Advances in Medicine and Biology. Volume 107

(sharon) #1

68 Usha Verma and Neil Verma


[78] Wildemeersch D, Janssens D, Pylyser K, De Wever N, Verbeeck G,
Dhont M, Tjalma W. Management of patients with non-atypical and
atypical endometrial hyperplasia with a levonorgestrel-releasing
intrauterine system: long-term follow-up. Maturitas. 2007;57:210–213.
[79] Dolapcioglu K, Boz A, Baloglu A. The efficacy of intrauterine versus
oral progestin for the treatment of endometrial hyperplasia. A
prospective randomized comparative study. Clin Exp Obstet Gynecol.
2013;40:122-126.
[80] El Behery MM, Saleh HS, Ibrahiem MA, Kamal EM, Kassem GA,
Mohamed Mel S. Levonorgestrel-releasing intrauterine device versus
dydrogesterone for management of endometrial hyperplasia without
atypia. Reprod Sci. 2015;22: 329-334.
[81] Kim MK, Seong SJ, Kim JW, Jeon S, Choi HS, Lee IH, et al.
Management of Endometrial hyperplasia With a levonorgestrel-
Releasing Intrauterine System: A Korean Gynecologic-Oncology Group
Study. Int J Gynecol Cancer. 2016;26:711-715.
[82] Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, Kooperberg C,
Stefanick ML, et al. Risks and benefits of estrogen plus progestin in
healthy postmenopausal women: principal results from the Women’s
Health Initiative randomized controlled trial. JAMA. 2 002;288:321–333.
[83] Hulley S, Grady D, Bush T, Furberg C, Herrington D, Riggs B,
Vittinghoff E. Randomized trial of estrogen plus progestin for secondary
prevention of coronary heart disease in postmenopausal women. Heart
and Estrogen/progestin Replacement Study (HERS) Research Group.
JAMA. 1998;280: 605–613.
[84] Andersson K, Mattsson LA, Rybo G, Stadberg E. Intrauterine release of
levonorgestrel – a new way of adding progestogen in hormone
replacement therapy. Obstet Gynecol. 1992;79:963–967.
[85] Riphagen FE. Intrauterine application of progestins in hormone
replacement therapy: a review. Climacteric. 2000;3:199–211.
[86] Hampton NR, Rees MC, Lowe DG, Rauramo I, Barlow D, Guillebaud J.
Levonorgestrel intrauterine system (LNG-IUS) with conjugated oral
equine estrogen: a successful regimen for HRT in perimenopausal
women. Hum Reprod. 2005;20:2653–2660.
[87] Depypere H1, Inki P. The levonorgestrel-releasing intrauterine system
for endometrial protection during estrogen replacement therapy: a
clinical review. Climacteric. 2015;18:470-482.

Free download pdf